Pixium Vision announces successful implantation of first patient in the US with the Prima Systemadmin2020-02-04T13:07:59+01:00January 13th, 2020|
Pixium Vision notified on threshold crossing following passive dilutionadmin2020-06-10T18:41:59+02:00December 23rd, 2019|
General Meeting and Board of Directors of December 12, 2019admin2020-06-13T08:51:21+02:00December 12th, 2019|
Pixium Vision and partners publish paper on photovoltaic subretinal prosthesis PRIMA in Nature Biomedical Engineeringadmin2019-12-23T11:39:34+01:00December 2nd, 2019|
Pixium Vision to present the 12 month data of its Dry-AMD PRIMA System at the 11th Eye and Chip World Research Congress on Artificial Visionadmin2020-06-10T18:50:55+02:00November 8th, 2019|
Pixium Vision announces a financing agreement for a maximum amount of €10 million issuing a first tranche of €1,25 millions, for the development of its PRIMA Systemadmin2020-06-10T18:36:08+02:00November 6th, 2019|
Proposed transfer of the listing of Pixium Vision’s shares to the Euronext Growth Paris marketadmin2019-12-23T11:47:57+01:00October 29th, 2019|
Pixium Vision reports cash position as of September 30, 2019admin2019-12-23T11:46:35+01:00October 24th, 2019|
Pixium Vision provides clarification on Omnes Capital shareholding unchanged since end 2017admin2019-12-23T11:40:31+01:00October 4th, 2019|
Pixium Vision announces H1 2019 financial results and provides business updateadmin2020-06-10T17:02:02+02:00July 25th, 2019|
Pixium Vision announced sustained success of its PRIMA System after 12-months in dry age-related macular degeneration patientsadmin2019-09-11T17:29:55+02:00July 18th, 2019|